Development of an interview-based warfarin nomogram predicting the time spent in the therapeutic INR range: A cost-effective, and non- invasive strategy building from a cross sectional study in a low resource setting

被引:3
|
作者
Anand, Aishwarya [1 ]
Kumar, Rupesh [2 ]
Gupta, Ankur [3 ,7 ]
Vijayvergiya, Rajesh [3 ]
Mehrotra, Saurabh [3 ]
Lad, Deepesh [4 ]
Barwad, Parag [3 ]
Sharma, Swati [5 ]
Patil, Amol N. [1 ,6 ]
机构
[1] Postgrad Inst Med Educ & Res PGIMER, Dept Pharmacol, Chandigarh, India
[2] Postgrad Inst Med Educ & Res PGIMER, Dept Cardiothorac & Vasc Surg, Chandigarh, India
[3] Postgrad Inst Med Educ & Res PGIMER, Dept Cardiol, Chandigarh, India
[4] Postgrad Inst Med Educ & Res PGIMER, Dept Internal Med, Chandigarh, India
[5] Postgrad Inst Med Educ & Res PGIMER, Dept Expt Med & Biotechnol, Chandigarh, India
[6] PGIMER, Dept Pharmacol, Chandigarh 160012, India
[7] PGIMER, Dept Cardiol, Chandigarh, India
关键词
Warfarin nomogram; Percent time in therapeutic range; INR; ATRIAL-FIBRILLATION;
D O I
10.1016/j.ihj.2022.03.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A cross-sectional study was conducted to predict time in therapeutic range (TTR) using clinical history, examination, and socioeconomic data. Study included warfarin-receiving patients from outpatient-clinic. In 203 patients studied, mean warfarin start-dose was 2.55 mg/day and maintenance-dose/week was 30.79 mg. Body mass index (BMI) (p = 0.03), warfarin maintenance dose/day (p = 0.02), and comorbidity presence (p = 0.04) were significantly associated with TTR. Occupation (p = 0.53), income (p = 0.83), education (p = 0.55), and socioeconomic score (p = 0.73) showed non-significant association with TTR. A TTR predicting nomogram was built from clinical history and examination findings. (c) 2022 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:245 / 248
页数:4
相关论文
empty
未找到相关数据